Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesPsychiatry/Behavioral HealthHealth Care Access Bureau PANDAS/PANS Coverage Upd…
    Ask Trek AI about this page
    CurrentHealth Care Access Bureau and Bureau of Managed Care, Division of InsurancePolicy N/A

    Required Coverage for Treatment of PANDAS and PANS

    Customize your policy alerts

    Sign up for all Health Care Access Bureau and Bureau of Managed Care, Division of Insurance policy alerts

    Know when Health Care Access Bureau and Bureau of Managed Care, Division of Insurance releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Bulletin directing Massachusetts commercial carriers and HMOs to provide coverage for medically necessary treatment of PANDAS and PANS, including IVIG, for insured plans issued or renewed in Massachusetts on or after January 1, 2022, and to ensure network access or temporarily cover out-of-network providers in‑network.

    Policy Summary
    PayerHealth Care Access Bureau and Bureau of Managed Care, Division of Insurance
    PolicyRequired Coverage for Treatment of PANDAS and PANS
    Policy CodePolicy N/A
    Change TypeStatutory coverage requirement added
    Effective DateJan 1, 2022
    Next Review DateN/A
    Key ActionCarriers must provide coverage for medically necessary PANDAS and PANS treatment, including IVIG, and ensure member access by identifying in‑network providers or covering out‑of‑network providers in‑network when necessary.
    SourceLink
    POLICY UPDATE CHANGES

    Carriers must provide coverage for treatment of PANDAS and PANS, including but not limited to intravenous immunoglobulin (IVIG) therapy.

    Requirement that the statutory provisions apply to insured health benefit plans issued or renewed in Massachusetts on or after January 1, 2022.

    Carriers must notify network providers and covered members, update administrative processes, identify in-network PANDAS/PANS providers, and cover out-of-network providers in-network if network access is inadequate.

    2022-01-01effective date for plans issued/renewed subject to the statute

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    2021-09-01deadline to forward provider materials
    Chapter 260legislative source

    When Services Are Covered

    Medically necessary treatment for PANDAS/PANS

    Covered when medically necessary for PANDAS or PANS patients

    Statutory coverage: Carriers must provide coverage for treatment of PANDAS and PANS, including but not limited to IVIG therapy, as required by Chapter 260 of the Acts of 2020.

    Applies to insured health benefit plans issued or renewed in Massachusetts on or after January 1, 2022.

    This bulletin implements the statutory requirement created by Chapter 260 that carriers must provide coverage for treatment of PANDAS and PANS. The statute specifically states coverage must include, but is not limited to, the use of intravenous immunoglobulin (IVIG) therapy for these conditions. The statutory provisions apply to insured health benefit plans that are issued or renewed in Massachusetts on or after January 1, 2022.

    Carriers are directed to align their coverage policies and administrative processes with the new statutory sections referenced in this bulletin. In addition to providing coverage for medically necessary PANDAS/PANS treatments including IVIG, carriers should ensure network adequacy for providers who can diagnose and treat these pediatric neuropsychiatric disorders and take steps to notify affected members and providers of the coverage requirements.

    If a carrier’s network does not include adequate access to clinicians who can provide medically necessary PANDAS/PANS services, the Division expects carriers to cover medically necessary services from out‑of‑network providers on an in‑network basis until adequate in‑network capacity is available. Carriers were also asked to identify and forward materials naming in‑network providers able to treat PANDAS/PANS to the Division by September 1, 2021.

    What Carriers and Providers Must Do

    Prior Authorization

    Statutory coverage requirement: include IVIG

    Carriers must provide coverage for treatment of PANDAS and PANS, including intravenous immunoglobulin (IVIG) therapy, consistent with Chapter 260; this coverage requirement applies to insured health benefit plans issued or renewed in Massachusetts on or after January 1, 2022.

    • Statutory text: carriers “provide coverage for treatment of pediatric autoimmune neuropsychiatric disorders … including, but not limited to, the use of intravenous immunoglobulin therapy.”
    • Effective date: provisions apply to plans issued or renewed in Massachusetts on or after January 1, 2022.
    Note

    Notify providers/members and update processes

    Carriers must notify network providers and covered members about PANDAS and PANS coverage and update administrative processes to enable access to medically necessary treatment for members both within and outside the Commonwealth.

    • Notify network providers and covered members about PANDAS/PANS coverage.

    Key Terms

    PANDAS/PANS definition and concise descriptors
    TermPANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections) and PANS (Pediatric Acute‑Onset Neuropsychiatric Syndrome)
    Core descriptionPediatric neuropsychiatric disorders covered by new statutory sections in Chapter 260 that require carriers to provide coverage for treatment of PANDAS and PANS.
    Included treatmentsStatute explicitly requires coverage including, but not limited to, intravenous immunoglobulin (IVIG) therapy.
    Applicability dateApplies to insured health benefit plans issued or renewed in Massachusetts on or after January 1, 2022.
    Regulatory sourceChapter 260 of the Acts of 2020 creating M.G.L. c. 175, §47NN; M.G.L. c. 176A, §8OO; M.G.L. c. 176B, §4OO; and M.G.L. c. 176G, §4GG.

    Covered Treatments and Modalities

    IVIG — treatment-specific criteria

    IVIG inclusion: Intravenous immunoglobulin (IVIG) therapy is explicitly included among treatments carriers must cover for PANDAS and PANS.
    Policy Summary
    PayerHealth Care Access Bureau and Bureau of Managed Care, Division of Insurance
    PolicyRequired Coverage for Treatment of PANDAS and PANS
    Policy CodePolicy N/A
    Change TypeStatutory coverage requirement added
    Effective DateJan 1, 2022
    Next Review DateN/A
    Key ActionCarriers must provide coverage for medically necessary PANDAS and PANS treatment, including IVIG, and ensure member access by identifying in‑network providers or covering out‑of‑network providers in‑network when necessary.
    SourceLink
    On This Page
    When Services Are CoveredWhat Carriers and Providers Must DoKey TermsCovered Treatments and Modalities
  1. Update administrative processes to enable members to access medically necessary PANDAS/PANS treatment.
  2. Documentation Required

    Identify in‑network PANDAS/PANS providers and report to the Division

    Carriers are expected to identify providers in their networks who can provide medically necessary PANDAS and PANS services and to forward materials to the Division identifying the names and locations of such providers by September 1, 2021.

    • Identify in‑network providers able to provide medically necessary PANDAS/PANS services.
    • Forward materials to the Division by September 1, 2021 listing names and locations of those providers.
    Denial Risk

    Cover out‑of‑network providers in‑network when access is inadequate

    If a Carrier’s network does not include adequate access to providers who can treat PANDAS and PANS, the Carrier must cover medically necessary PANDAS and PANS services from out‑of‑network providers on an in‑network basis until an adequate network is developed.

    • Temporary in‑network coverage applies to medically necessary services from out‑of‑network providers when network access is inadequate.
    • This requirement remains until the Carrier develops an adequate in‑network provider network for PANDAS/PANS.